Biofire Blood Panel (BCID)
New
18,000.00₹
In stock
All over India
0 Reviews
The BioFire Blood Panel (BCID), such as the BCID2 panel, is a rapid multiplex polymerase chain reaction (PCR) diagnostic test designed to identify bloodstream pathogens directly from positive blood culture bottles.
This comprehensive assay detects a wide array of genetic targets, including Gram-positive bacteria, Gram-negative bacteria, and yeasts, alongside critical antimicrobial resistance genes. Delivering results in approximately one hour with minimal hands-on time, the test empowers clinicians to quickly transition patients from broad-spectrum empiric therapy to targeted treatments, significantly improving antimicrobial stewardship and clinical management for severe infections like sepsis.
This comprehensive assay detects a wide array of genetic targets, including Gram-positive bacteria, Gram-negative bacteria, and yeasts, alongside critical antimicrobial resistance genes. Delivering results in approximately one hour with minimal hands-on time, the test empowers clinicians to quickly transition patients from broad-spectrum empiric therapy to targeted treatments, significantly improving antimicrobial stewardship and clinical management for severe infections like sepsis.
The BioFire Blood Panel (BCID), such as the BCID2 panel, is a rapid multiplex polymerase chain reaction (PCR) diagnostic test designed to identify bloodstream pathogens directly from positive blood culture bottles.
This comprehensive assay detects a wide array of genetic targets, including Gram-positive bacteria, Gram-negative bacteria, and yeasts, alongside critical antimicrobial resistance genes. Delivering results in approximately one hour with minimal hands-on time, the test empowers clinicians to quickly transition patients from broad-spectrum empiric therapy to targeted treatments, significantly improving antimicrobial stewardship and clinical management for severe infections like sepsis.
